Bacteria have many strategies for defending themselves against antibiotics. Some destroy the drug, others pump it out or alter its target. They can also, more simply, prevent it from getting in. A team at the University of Geneva (UNIGE) has discovered how Pseudomonas aeruginosa, a bacterium responsible for infections that are often difficult to treat, very rapidly restricts the entry of imipenem, an antibiotic reserved for the most critical cases. Published in the Proceedings of the National Academy of Sciences, these findings reveal a mechanism of antibiotic resistance and open up new avenues for eventually counteracting it.
❓ Unknown
Pathogen P. aeruginosa uses protein to limit entry of last-resort antibiotic
Just now
November 20, 2026
1 min read
📰 Phys.org
📋 Key Takeaway
This article is not about Iran. It reports on research from the University of Geneva regarding how the bacterium Pseudomonas aeruginosa resists the antibiotic imipenem by restricting its entry into cells. The findings have no direct relevance to Iranian affairs or politics.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
8 min ago •
Republicans in Senate Block Resolution to Limit Trump's War Powers Against Iran
13 min ago •
Resolution to Limit Trump's War Powers Rejected by U.S. Senate
14 min ago •